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Endothelins are vascular-derived axonal guidance
cues for developing sympathetic neurons
Takako Makita1, Henry M. Sucov2, Cheryl E. Gariepy3, Masashi Yanagisawa4 & David D. Ginty1
During development, sympathetic neurons extend axons along a
myriad of distinct trajectories, often consisting of arteries, to
innervate one of a large variety of distinct final target tissues.
Whether or not subsets of neurons within complex sympathetic
ganglia are predetermined to innervate select end-organs is
unknown. Here we demonstrate in mouse embryos that the
endothelin family member Edn3 (ref. 1), acting through the
endothelin receptor EdnrA (refs 2, 3), directs extension of axons
of a subset of sympathetic neurons from the superior cervical
ganglion to a preferred intermediate target, the external carotid
artery, which serves as the gateway to select targets, including the
salivary glands. These findings establish a previously unknown
mechanism of axonal pathfinding involving vascular-derived
endothelins, and have broad implications for endothelins as
general mediators of axonal growth and guidance in the devel-
oping nervous system. Moreover, they suggest a model in which
newborn sympathetic neurons distinguish and choose between
distinct vascular trajectories to innervate their appropriate end
organs.
The sympathetic division of the autonomic nervous system is
composed of preganglionic sympathetic neurons, derived from the
neuroectoderm, and their synaptic targets, neural-crest-derived
postganglionic sympathetic neurons, the cell bodies of which reside
within paravertebral and prevertebral sympathetic ganglia.
Postganglionic sympathetic neurons (referred to hereafter as sym-
pathetic neurons) innervate and control a wide range of targets,
including exocrine and endocrine glands and ducts, smooth muscle
layers of the intestine and blood vessels, cardiac muscle and nodes,
and pilomotor muscles. Sympathetic neurons originate during
development when neural crest cells bilaterally delaminate from
the neural tube, migrate and assemble into ganglia. In mouse
embryos, aggregation of neural crest cells into sympathetic chain
ganglia initiates at approximately embryonic day 10.5 (,E10.5),
adjacent to the dorsal aorta. The cranial-most sympathetic ganglia,
the superior cervical ganglia (SCG), ultimately come to reside adja-
cent to the bifurcation of the internal and external carotid arteries
from the common carotid arteries. Sympathetic neurons of the SCG
send axonal projections either along the external carotid arteries to
innervate the submandibular, sublingual and parotid glands or along
the internal carotid arteries to the lacrimal and pineal glands, the eye,
blood vessels and skin of the head, and the mucosa of the oral and
nasal cavities.
A fundamental, unanswered question is how subsets of neurons
within any complex autonomic ganglion, such as the SCG, acquire
characteristic molecular and functional properties appropriate for
the control of their respective end organs. One model posits
that axons emanating from the SCG or other ganglia grow along
intermediate targets, such as blood vessels, in a random or stochastic
manner, and that it is the end organ that retrogradely specifies mor-
phological and biochemical features, presynaptic connections and
physiologic properties of the innervating neuron. Evidence in sup-
port of this model derives from the observation that a small subset of
sympathetic neurons acquires a cholinergic transmitter phenotype
on innervation of eccrine sweat glands and acquisition of a sweat-
gland-derived cholinergic differentiation factor (CDF)4. A second
model posits that subpopulations of newly born sympathetic neurons
are molecularly distinct; these subpopulations choose from several
intermediate target structures, such as particular blood vessels that
serve to guide axonal trajectories to their appropriate end organs.
Identification of axonal guidance cues that direct select subsets of
sympathetic axons towards one or another vascular path would serve
as evidence in support of the latter model. We therefore asked
whether axons of developing sympathetic neurons of the SCG choose
between extending along either the internal or the external carotid
arteries because these blood vessels provide the main routes by which
SCG axons project to distinct end-organs in the head and neck. These
investigations led us to define the molecular identity of the cues
and their receptors that guide extending axons along the vascular
network.
In mouse embryos, the SCG form in the upper thorax by E11.5 as a
condensation of neural precursors dorsal to the outflow tract of the
heart. SCG neurons extend axons cranially along the primitive
internal carotid arteries (derived from the dorsal aortae; Fig. 1a, d).
At this stage, the external carotid arteries are beginning to emerge
from the third pharyngeal arch arteries near their origins from the
aortic sac5; there are no projections of sympathetic axons along either
the nascent external carotid arteries or the third arch arteries (Fig. 1a,
g). By E12.5, the common carotid arteries have elongated and the
external carotid arteries are substantially developed. At this time, the
sympathetic chain has become delimited into distinct ganglia and
the SCG are clearly distinct from the more caudal stellate ganglia.
Sympathetic neurons initiate extension of axons towards the external
carotid arteries at this time, originating from the SCG at the level of
the junction of the base of internal and external carotid arteries
(Fig. 1b, m, p); the SCG extends cranially along the internal carotid
arteries as far as the stapedial arteries (Fig. 1b, j). By E13.5, SCG
axonal projections associated with both the external and internal
carotid arteries are more substantially developed, although the
general pattern of blood vessels and axonal projections is the same
as the previous day (Fig. 1c, q, t, w and Supplementary Figs 1 and 2).
Previous studies using Wnt1Cre and R26R mice have defined the
neural crest and mesodermal origins of vascular smooth muscle in
the cardiac outflow tract and great blood vessels, although not spe-
cifically of the vascular segments relevant for SCG projections6,7. The
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third pharyngeal arch arteries are lined by neural-crest-derived
smooth muscle (Fig. 1h, i). Consequently, their derivatives, which
include the entirety of the external carotid arteries and the base of the
internal carotid arteries, also have a neural crest origin (Fig. 1n, o, u, v
and Supplementary Fig. 2). In contrast, the dorsal aortae are lined by
smooth muscle that is mesodermal in origin (Fig. 1h, i) and, as a
result, the internal carotid arteries from just above their origination
from the common carotid arteries have a mesoderm-derived smooth
muscle layer (Fig. 1e, f, k, l, r, s and Supplementary Fig. 2). Thus, the
smooth muscle layers of the internal and external carotid arteries
arise from different cell lineages and may therefore also be molecu-
larly distinct. These arteries may, therefore, serve as distinct axonal
growth environments that preferentially attract one, but not the
other, of the two main axon bundles emanating from the SCG.
To address this possibility and to identify previously unknown
vascular-derived guidance cues for SCG neurons that are selectively
expressed by the crest-derived external carotid and the mesoderm-
derived internal carotid arteries, we isolated these vascular segments
from embryos at E13.5 and extracted RNA to screen microarrays for
differentially expressed genes. Transcripts for endothelin converting
enzyme 1 (ECE1), the protease responsible for conversion of inactive
precursors (big endothelins) to bioactive forms of endothelins8,9,
were identified as being selectively expressed in the developing
external carotid arteries.
To confirm this finding, and to address the role of endothelins
and their cell surface receptors in SCG axonal guidance, we next
examined the expression patterns of endothelin signalling compo-
nents by in situ hybridization on serial sections from Wnt1Cre/R26R
embryos at E11.5–E14.5. X-gal staining was used to identify neural-
crest-derived cells, and alpha-smooth muscle actin (SMA) immuno-
histochemistry was used to label smooth muscle. We found that Ece1
was selectively expressed in the neural-crest-derived smooth muscle
layer of the external carotid arteries, but was absent, or present at
much lower levels, in mesoderm-derived smooth muscle of the
internal carotid arteries (Fig. 2b, h). Ece1 mRNA was most abundant
at E11.5 in the third pharyngeal arch arteries (the source of the
external carotid arteries), was somewhat lower at E12.5 in the newly
formed external carotid arteries, and was only marginally detectable
at E13.5 and E14.5 (data not shown). At all stages examined, ECE1
was preferentially associated with the external carotid arteries relative
to the internal carotid arteries. Expression of Ece2 has been described,
and is not found in this region until E13.5 (when it begins to be
expressed in scattered clusters of neurons in the neural tube, dorsal
root ganglia and sympathetic ganglia10). Of the three endothelins1,
endothelin 3 (Edn3) mRNA was found at the highest level, and was
preferentially expressed around the third arch arteries at E11.5 and
associated with the external carotid arteries at E12.5, although there
was a small amount of expression detected around the internal
carotid arteries at E11.5 and E12.5 (Fig. 2d, j). Similar to Ece1,
Edn3 expression was highest at E11.5, was somewhat diminished at
E12.5, and was maintained at a low level at E13.5–E14.5. Edn2 was
not appreciably expressed in this region during this developmental
period (Fig. 2e, k), and Edn1 was expressed in endothelial cells and
some scattered smooth muscle and mesenchymal cells at a relatively
low level (Fig. 2f, l). Quantitative real-time PCR measurements using
dissected internal and external carotid arteries confirmed the selec-
tive expression of Ece1 and Edn3 associated with the external carotid
arteries (Fig. 2m). Both endothelin receptor genes, Ednra and Ednrb,
encoding EdnrA and EdnrB, respectively2,3, were expressed in sub-
populations of SCG neurons (Fig. 2n–v). Ednra expression persists
through E12.5, although expression abated by E13.5 (Fig. 2u) and
was nearly undetectable at E14.5 (data not shown). Expression of
Ednrb, in contrast, was sustained in a small subset of SCG neurons
at E13.5 (Fig. 2v) and E14.5 (data not shown). Thus, although pre-
viously not appreciated to function in axonal growth and guidance,
the spatial and temporal patterns of expression of endothelins, the
ECE1 processing enzyme and the endothelin receptors suggest a role
for endothelin signalling in guiding subsets of sympathetic axons
towards either the internal or the external carotid arteries.
We next used cultured SCG explants grown in a collagen gel sup-
port11 to ask whether endothelins have the capacity to influence
axonal outgrowth of sympathetic axons in vitro. Indeed, robust
extension of neurites from E12.5 SCG explants was observed when
any of three endothelins was mixed uniformly into the collagen gel,
whereas little or no neurite outgrowth was observed when bovine
serum albumin (BSA) was provided. SCG explants obtained from
E13.5 embryos were equally responsive to endothelins, but no res-
ponse was observed in E14.5 SCG (Fig. 3a, Supplementary Fig. 3a).
To ask whether endothelins are capable of attracting sympathetic



































































Figure 1 | Development of vascular and sympathetic systems. a–c, India
ink visualization of the carotid arteries. The red lines indicate the
approximate levels of sections shown in d–w. d–w, Serial transverse sections
at the approximate levels indicated in panels a–c were stained with X-gal or
immunostained for TH or alpha smooth muscle actin. d–f, j–l and q–s are
sections through the internal carotid artery. g–i, m–p and t–w are at the level
of the carotid bifurcation and show the base of the internal and external
carotid arteries. m, t, Arrows denote SCG axons extending along the external
carotid artery. Low-magnification views of the same sections are provided in
Supplementary Fig. 1. At least ten embryos at each stage were analysed in this
manner with comparable results. p, w, Confocal immunofluorescent images
of sections of E12.5 and E13.5 embryos at a level approximately as indicated
in b and c, respectively, showing TH-positive axons (red) projecting along
the smooth muscle layer (green) of the base of internal and external carotid
arteries (yellow arrows). Abbreviations: 3, 4 and 6, third, fourth and sixth
pharyngeal arch arteries, respectively; bic, base of internal carotid artery;
cc, common carotid artery; dAo, dorsal aorta; ec, external carotid artery;
ic, internal carotid artery; pec, primitive external carotid artery; pic, primitive
internal carotid artery; sa, stapedial artery; sc, sympathetic chain; and scg,
superior cervical ganglion. Scale bars, 100mm.
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axons, we next placed E12.5 SCG explants in proximity to beads
soaked with endothelins. Human EDN3 seemed to be most effective
in this regard (Fig. 3b, middle, and Supplementary Fig. 3b), although
EDN1 and EDN2 also promoted directional outgrowth (data not
shown). Moreover, when beads soaked with a high concentration of
EDN3 were placed adjacent to SCG explants, random or undirected
outgrowth was observed in addition to directional outgrowth (Fig. 3b,
right). Thus, axonal outgrowth is a concentration-dependent and
possibly gradient-dependent process. To determine which endothelin
receptor mediates this response, we treated E12.5–E13.5 SCGs with
EDN3 in the presence or absence of endothelin-receptor-selective
antagonists. The EdnrA antagonist BQ123 (ref. 12) completely elimi-
nated SCG neurite outgrowth, whereas the EdnrB antagonist BQ788
(ref. 13) was ineffective (Fig. 3c, upper row, and Supplementary
Fig. 3c). In contrast, outgrowth from the Xth cranial (CN X/vagal)
ganglia explants, which express both endothelin receptors (data not
shown), was selectively blocked by the EdnrB antagonist (Fig. 3c, lower
row, and Supplementary Fig. 3d). We conclude that EDN3–EdnrA
signalling is a potent mediator of SCG neurite outgrowth in vitro.
We next asked whether endothelins govern axonal guidance deci-
sions of sympathetic neurons as they encounter the choice of project-
ing to either the internal or the external carotid arteries in vivo. For
these experiments, SCG axonal projections in mice harbouring null
mutations in genes encoding endothelin signalling components were
assessed. Although EDN2 can promote axonal extension in vitro,
Edn2 is not expressed in vascular smooth muscle, and Edn2-null
mouse embryos exhibited normal SCG axonal growth along both
the internal and the external carotid arteries (data not shown).
Similarly, spotting lethal mutant rat embryos, which carry a loss-of-
function mutation in the Ednrb gene14, also displayed normal SCG
axonal projections (Supplementary Fig. 4). Thus, consistent with our
BSA EDN1 EDN2 EDN3






































Figure 3 | Endothelins promote SCG neurite outgrowth in vitro. a, SCGs
from embryos at the indicated stages were harvested and grown in collagen
gels prepared with the indicated endothelins (10 nM) or BSA. The average
amount of neurite outgrowth from seven separate experiments is shown in
Supplementary Fig. 3a. b, Heparin–agarose beads soaked in the indicated
concentration of EDN3 or BSA were placed adjacent to E12.5 SCG. Dotted
circles indicate the location of the beads. The extent of directional outgrowth
was assessed by the relative amount of outgrowth in the proximal direction
relative to the distal direction of the beads, as shown in Supplementary Fig.
3b. c, E12.5 SCG (top row) or vagal (bottom row) explants were grown in
collagen gels in the presence of EDN3 (5 nM) and the EdnrA antagonist
BQ123 (1mM) or the EdnrB antagonist BQ788 (100 nM) as indicated.
Quantification of EDN3-induced neurite outgrowth influenced by each




























































a b c d e f





Figure 2 | Expression of endothelin signalling components. a–l, Serial
frontal sections of E11.5 (a–f) and E12.5 (g–l) Wnt1Cre/R26R embryos,
stained with X-gal, immunostained for SMA, or digoxygenin-labelled by in
situ hybridization for the indicated genes. m, Quantitative real-time PCR
analysis. Total RNA was extracted from dissected vascular segments from
five individual E12.5 wild-type embryos isolated from two different litters.
Total RNA was reverse transcribed, and was evaluated for gene expression by
quantitative real-time PCR as described in the Methods. Expression levels
were normalized to the amount of GAPDH transcripts and are scaled as
absolute values. ic and ec, internal and external carotid artery segments. The
grey bars represent the signal associated with the internal carotid arteries,
whereas the black bars represent the signal associated with the external
carotid arteries. ND, not detected. Error bars, mean 6 s.e.m.;
*P , 0.01; **P , 0.005. n–v, Serial frontal sections of embryos at the
indicated stages immunolabelled for TH or labelled by in situ hybridization
for Ednra and Ednrb. Sections shown at E11.5 are through the rostral end of
the sympathetic chain, and at E12.5 and E13.5 are through the SCG. Results
were confirmed with sections from at least five embryos of each stage. Scale
bars, 100mm.
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in vitro results, EdnrB is not required for directed SCG axonal exten-
sion. Ece2 mutant embryos10 also exhibited normal SCG axonal out-
growth (data not shown). In contrast, Ednra mutant embryos15
exhibited a complete lack of SCG axonal extension along the external
carotid arteries (Fig. 4c, i). This axonal projection deficit is specific
for the external carotid arteries; Ednra mutants exhibited normal
SCG axonal projections along the internal carotid arteries (Fig. 4a,
b, g, h). The axonal projection defect in Ednra mutants is not due to
defective smooth muscle cell differentiation, as shown by SMA stain-
ing (Fig. 4d–f, j–l). Edn3 serves as a ligand that promotes EdnrA
signalling in this context because Edn3 mutant embryos16 showed a
similar although slightly less severe phenotype compared to that of
the Ednra mutants, in which SCG axons failed to fully extend along
the external carotid arteries (Fig. 4o, r). In Edn3 mutants, SCG neu-
rons did extend some processes around the carotid bifurcation, albeit
to a much lesser extent than littermate controls, and they initiated a
small and poorly developed projection along the proximal section of
the external carotid arteries. Even at E15.5, the latest time point ana-
lysed, axonal projections from the SCG along the external carotid arter-
ies and their branches were markedly deficient in Edn32/2 embryos
(Supplementary Fig. 5). We note that Edn1 is also expressed in the
vicinity of the developing SCG, and thus Edn1 may have some func-
tional overlap with Edn3 to support modest SCG extension along the
external carotid arteries. Moreover, as observed for the Ednra mutants,
Edn3-null axons extended along the internal carotid arteries and their
branches normally (Fig. 4m, n, p, q and Supplementary Fig. 5).
These in vivo and in vitro findings collectively implicate Edn3 as a
vascular-derived sympathetic axon growth factor. We suggest that
Edn3, released from the neural-crest-derived smooth muscle layer of
the external carotid arteries, directs those SCG neurons destined to
innervate the salivary glands to send axonal projections along the nas-
cent external carotid arteries—the sole pathway to these end organs.
Interestingly, our analysis demonstrates that Edn3–EdnrA signalling is
not required for projections to the internal carotid arteries. Because
embryonic SCGs do not spontaneously exhibit axonal outgrowth, at
least in vitro, we predict that other factors expressed by the mesoderm-
derived smooth muscle layer of the internal carotid artery direct pro-
jections from the SCG towards this blood vessel. It is noteworthy that
the smooth muscle layer of the external carotid arteries originates from
the third pharyngeal arch neural crest. Moreover, endothelin signalling
also contributes to development of additional third pharyngeal arch
structures and other aspects of cardiovascular and craniofacial
development15, all of which are also dependent on neural crest cell
progeny. Furthermore, endothelin receptors are broadly and dynam-
ically expressed in these and other neural crest derivatives. Thus, it will
be of interest to ask whether endothelins serve as axonal growth and
guidance cues for other neural projections associated with third pha-
ryngeal arch structures and other neural crest derivatives, such as the
thymus, thyroid, cardiac outflow tracts and various craniofacial struc-
tures. Likewise, endothelins are expressed in the brain and in a variety
of mesoderm-derived tissues17 and, therefore, may serve as guidance
cues for many distinct populations of developing neurons.
Our observations indicate that Ednra expression within the SCG is
variegated, suggesting that only a subset of SCG neurons can respond
to endothelins and project to the external carotid arteries. The basis
of this endothelin receptor heterogeneity within the SCG is
unknown; it may arise by stochastic events, by a form of lateral
inhibition within the ganglion, or by predetermination within the
neural crest sublineage that gives rise to SCG neurons. We do not yet
know if EdnrA-positive neurons are also able to project to the
internal carotid arteries although, clearly, EdnrA-negative neurons
are unable to project to the external carotid arteries. Therefore, we
suggest a model in which developing sympathetic neurons are pre-
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Figure 4 | Edn3 and its receptor EdnrA are essential for SCG axonal
projections along the external but not internal carotid arteries in mouse
embryos. a–l, Histological sections stained with TH or SMA from an E13.5
Ednra2/2 embryo and a littermate control. Three mutant embryos analysed
from multiple litters exhibited a complete absence of axons along the
external carotid artery, similar to the embryo shown in g–l. m–r, Histological
sections from an E13.5 Edn32/2 embryo and a littermate control stained
with TH. Seven Edn32/2 embryos analysed at E13.5 or older from multiple
litters had defects in axonal projections towards the external carotid arteries.
Sections shown in the top row are all at the cochlea–pituitary level, and show
the rostral projection from the SCG along the internal carotid artery. Shown
in the middle row are sections at the level of the branch of the stapedial artery
from the internal carotid artery; these reveal the cranial-most extent of the
SCG and the initial projection from the SCG to the internal carotid artery.
Sections in the lower row were taken at a level immediately above the
bifurcation of the external and internal carotid arteries from the common
carotid artery. Arrows point to the presence (in panels c and o) or the
absence (in i and r) of axonal projections to the external carotid artery.
Abbreviations: co, cochlea; pt, pituitary gland; V, trigeminal ganglion;
*, histological artefact. Scale bar, 100mm.
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thus destined to innervate select end organs. This choice of vascular
route is guided, at least in part, by the actions of vascular-derived
endothelins.
METHODS SUMMARY
The Wnt1cre18, R26R19, Ednra15, spotting lethal14, Edn3 (ref. 16) and Ece2 (ref. 10)
alleles have been described previously. X-gal staining and SMA immunostaining
of frozen sections were as described previously6,7. Tyrosine hydroxylase (TH;
Chemicon) immunoreactivity was visualized using an horseradish peroxidase
(HRP)-conjugated secondary antibody and a diaminobenzidine (DAB) detec-
tion system. For in situ hybridization reactions, digoxygenin (DIG)-labelled
antisense probes were generated for each gene, and the hybridization signal
was detected using an alkaline phosphatase (AP)-conjugated anti-DIG antibody
and 5-bromo-4-chloro-indolylphosphate/nitroblue tetrazolium (BCIP/NTB;
Roche). For explant cultures, SCGs were cut into pieces on dissection, and placed
into a collagen gel11. Explants were grown in the absence or presence of endothe-
lins (Alexis), endothelin- or BSA-soaked heparin–agarose beads (Sigma), or the
endothelin receptor antagonists BQ123 or BQ788 (AG Scientific) in Leibovitz-
L15(L15)-CO2 medium supplemented with 5% fetal bovine serum (FBS) for
three days.
Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
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METHODS
Histology and immunohistochemistry. Glutaraldehyde-fixed embryos were
cryopreserved in sucrose. Five- or ten-micrometre cryosections were post-fixed,
stained with X-gal by standard procedures, and counterstained with nuclear fast
red. Glutaraldehyde- or paraformaldehyde-fixed embryos were cryopreserved
and sectioned at 5- or 10-mm thickness for immunostaining. The primary
antibodies used were TH (1:400; Chemicon) or alpha-smooth muscle actin
(1:1,000; Sigma), and visualized using an HRP-conjugated secondary antibody
and DAB/H2O2 detection system. For histological examination of sympathetic
axonal phenotypes in mutant embryos, all cervical–thoracic sections were
immunostained with TH. Alternatively, alternate sections from cervical to
thoracic levels were subjected to hematoxylin–eosin staining and TH and SMA
immunohistochemistry.
Microarray analysis. Vascular segments (the internal and external carotid
arteries) were visualized by India ink injection into the left ventricle and dissected
from 22 E13.5 mouse embryos, pooled, and total RNA extracted. Comple-
mentary RNAs, synthesized from complementary DNAs made from two rounds
of amplification of each RNA sample, was used to hybridize and screen
Affymetrix microarrays (MOE430_2) for differentially expressed genes by the
JHMI Microarray Core Facility.
In situ hybridization. Histological sections from glutaraldehyde-fixed Wnt1-
Cre/R26R embryos were used for in situ hybridization reactions. Digoxygenin-
labelled sense and antisense probes were generated for Ece1 (corresponding to
nucleotides 2308–2532 of NM_199307), Edn1 (834–988 of NM_010104), Edn2
(747–851 of NM_007902), Edn3 (1492–1713 of NM_007903), Ednra (565–991
of NM_010332) and Ednrb (1250–1563 of NM_007904), and the hybridization
signal was detected using an alkaline-phosphatase-conjugated anti-digoxygenin
antibody and BCIP/NTB (Roche).
Collagen gel culture. Vascular structures in E12.5 and E13.5 embryos were
visualized by injection of India ink, and SCGs and CN Xs were dissected in
PBS. SCGs were cut into several pieces and placed into a collagen gel as described
previously11. Explants were grown in the absence or presence of synthetic
endothelins (EDN1, EDN2 or EDN3, Alexis), the endothelin receptor selective
antagonists BQ123 or BQ788 (AG Scientific), or endothelin- or BSA-soaked
heparin–agarose beads (Sigma) in L15CO2 medium supplemented with 5%
FBS for three days. Synthetic endothelins and receptor antagonists were applied
at concentrations ranging from 1 nM to 100 nM and from 10 nM to 10mM,
respectively, to optimize assay conditions before performing the experiments.
Neurite outgrowth was evaluated by immunostaining explants with anti-
neurofilament (2H3) (1:150, Developmental Studies Hybridoma Bank) followed
by immunofluorescence detection using fluorescein-conjugated secondary anti-
bodies. To quantify neurite outgrowth, the length of neurites extending from
explants was measured using an Image J image processing program.
Quantitative real-time PCR analysis. Vascular segments (the internal and
external carotid arteries) were visualized by injection of India ink into the left
ventricle and dissected from E12.5 mouse embryos. Total RNA was extracted
from individual vascular segment by guanidinium isothiocyanate extraction and
were reverse transcribed using standard conditions. All samples were analysed
independently by real-time PCR using an iCycler iQ with SYBR green supermix
(Bio-Rad).
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